Jianhong Zhong

56PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jun 02, 2026
Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008).

|Mar 27, 2026
Construction of TLS-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.

Jian-Rong Li, Li-Xin Pan, Jia-Yong Su

|Mar 13, 2026
Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002).

Da-Long Yang, Chuang Qin, Ning Peng

|Feb 17, 2026
Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection.

Jia-Yong Su, Qiu-Jian Qin, Jian-Yuan Meng

|Sep 29, 2025
The SMIM25-COX-2 Axis Modulates the Immunosuppressive Tumor Microenvironment and Predicts Immunotherapy Response in Hepatocellular Carcinoma.

Zhenxing Wang, Xia Li, Shiyi Zhang

|Aug 20, 2025
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study.

Guoming Shi, Xiaoyong Huang, Liang Ma

Pageof 10

Frequent Collaborators

3 joint publications

Jia-Yong Su

2 joint publications

Liang Ma

1 joint publications

C C N Chong

1 joint publications

Xue-Mei You